1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow CID S.p.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions CRE8 sirolimus-eluting stent, RESOLUTE zotarolimus-eluting stent - Coronary Artery Disease | Phase 3 | Unknown | CID S.p.A. | 430 | 2014-11-01 | 2015-03-25 |
China (1)
Shubin Qiao, MD (1)